Search PubMed⌕ Search

Biomedical subjects

S Lehmann

Publications and source records attributed to S Lehmann.

At least 73 records · Page 4Linked to original sources

A mutant prion protein displays an aberrant membrane association when expressed in cultured cells.

Inherited forms of prion disease have been linked to mutations in the gene encoding PrP, a neuronal and glial protein that is attached to the plasma membrane by a glycosyl-phosphatidylinositol (GPI) anchor. One familial form of Creutzfeldt-Jakob disease is associated with a mutant PrP containing six additional octapeptide repeats. We report here our analysis of cultured Chinese hamster ovary cells expressing a murine homologue of this mutant PrP. We find that, like wild-type PrP, the mutant protein is glycosylated, GPI-anchored, and expressed on the cell surface. Surprisingly, however, cleavage of the GPI anchor using phosphatidylinositol-specific phospholipase C fails to release the mutant PrP from the surface of intact cells, suggesting that it has an additional mode of membrane attachment. The phospholipase-treated protein is hydrophobic, since it partitions into the detergent phase of Triton X-114 lysates; and it is tightly membrane-associated, since it is not extractable in carbonate buffer at pH 11.5. Whether membrane attachment of the mutant PrP involves integration of the polypeptide into the lipid bilayer, self-association, or binding to other membrane proteins remains to be determined. Our results suggest that alterations in the membrane association of PrP may be an important feature of prion diseases.

Amino Acid Sequence↗

Prevalence of the fimbrial antigens F18 and K88 and of enterotoxins and verotoxins among Escherichia coli isolated from weaned pigs.

Until recently, the fimbrial F18 antigen has been provisionally designated F107, 2134P, or 8813. Using the slide agglutination test, this antigen was shown to be present on 139 of 160 Escherichia coli strains of type O139:K82 and on all of the 146 K88-negative strains of the other pathogenic porcine serotypes. These strains were isolated from weaned pigs which in most cases had died from postweaning colibacillosis. All strains were haemolytic. With only three exceptions, they produced verotoxin and/or enterotoxin. The F18ab variant strongly predominated on the O139:K82 strains and was found on about half of the O138:K81 strains and a few O157 strains, whereas the other strains carried the F18ac variant. In serotypes which can carry either F18 or K88 fimbriae, closer clonal relationships between the strains associated with F18 and those associated with K88 were missing.

Animals↗

An endogenous lectin and its glycoprotein ligands are triggering basal and axon-induced Schwann cell proliferation.

The proliferation of Schwann cells (the myelinating cells of the peripheral nervous system) is stimulated by the contact with axonal membranes. It is suggested that the endogenous carbohydrate-binding protein (lectin) cerebellar soluble lectin (CSL) bound to ligands at the surface of axonal preparations is mitogenic for Schwann cells. Both autocrine and axon-stimulated Schwann cell proliferations seem to be dependent on the presence of CSL and its ligands at the Schwann cell surface, as suggested by the effects of N-glycosylation inhibitors and anti-CSL Fab fragments. These data suggest that CSL regulates Schwann cell proliferation by clustering of a few glycoprotein ligands at the cell surface, consequently modulating phosphorylations.

1-Deoxynojirimycin↗

Presence of anti-CSL antibodies in the cerebrospinal fluid of patients: a sensitive and specific test in the diagnosis of multiple sclerosis.

The carbohydrate-binding protein (lectin) CSL is an antigen involved in the stabilization of the myelin structure by interacting with the carbohydrate moiety of myelin glycoproteins. Since anti-CSL Fab fragments were able to produce destruction of CNS myelin in vitro, CSL was considered as a potential immunological target in multiple sclerosis. The presence of anti-CSL antibodies has been examined in the cerebrospinal fluid of 1388 different patients with various neurological diseases. It is concluded that the presence of anti-CSL antibodies in the cerebrospinal fluid of patients less than 50 years old constitutes a very sensitive and specific test for multiple sclerosis.

Antibodies↗

Differential expression of an endogenous mannose-binding protein R1 during muscle development and regeneration delineating its role in myoblast fusion.

The role of the endogenous brain carbohydrate-binding protein R1 in muscle cell development and regeneration was analysed both in vivo and in vitro. In vivo, R1 was developmentally regulated, with an embryonic 65,00 subunit and a neonatal 67,000 subunit, being replaced progressively by a 135,000 adult form. Lectin R1 was intracellularly localized at birth and in the prenatal period. During development and at the time of myoblast fusion, the antigen was progressively found at the surface, where it remained at low levels in the adult. In vitro, in pure myoblast cultures, only the embryonic form was present. The ultrastructural studies indicated that the lectin could participate in the membrane fusion process during myoblast fusion. The specific role in myoblast fusion, derived from the ultrastructural localization of R1, was evidenced by a strong inhibitory effect of anti-R1 Fab fragments (10-100 micrograms/ml), relative to control Fab fragments. In vivo, the embryonic subunit pattern and subcellular distribution of R1 reappeared in muscle cells after lesion of the adult muscle. This suggested that, as observed in vitro, R1 participated in vivo in the phenomenon of myoblast fusion. Similar modifications in subunit expression were observed in muscles after denervation (the embryonic form of lectin R1 reappearing after lesion), suggesting that R1 could be involved in the process of neuromuscular junction formation. Thus, it is proposed that the carbohydrate-binding protein R1 is an important recognition molecule for the formation of myotubes. Its potential involvement in a recognition process between axons and muscle cells during neuromuscular junction formation is discussed.

Animals↗

A new approach to determining homopolymer domain sizes in polycarbonate-polyether dialysis membranes by solid-state NMR.

The size of micro-separated domains of polyether (PEO), -[CH2CH2O]n-, and polycarbonate (PC), -[(C6H4)-C(CH3)2-(C6H4)-OCO2]m-, in the dialysis membrane 'Gambrane' have been determined using an advanced solid-state NMR technique which exploits differences in 1H spin diffusion. The characteristic diameter of a PEO domain is 4.8 +/- 1.4 nm and that of PC is 5.2 +/- 1.4 nm with a mixed phase region of 0.8 +/- 0.5 nm.

Dialysis↗

[Detection of verotoxin-producing E. coli in field isolates from domestic and agricultural animals in Sachsen-Anhalt].

A report is given on the detection of verotoxin-producing E. coli (VTEC) strains from field isolates of healthy or ill cattle (n = 141), pigs (n = 306), sheep (n = 15), cats (n = 29) and dogs (n = 25) in the region of the new federal land Sachsen-Anhalt. 5% of the strains isolated from cattle, 32% from pigs, 20% from sheep, 4% from dogs and 0% from cats have shown VTEC. The E. coli-strains were checked for the presence of other factors of virulence, too. A good correlation (82%) was found between the colonization factor F107 and SLT 2/2v-containing strains from pigs in the region of Sachsen-Anhalt, too. Enterohemolysin was not found in SLT 2/2v-positive strains. 91% of the VTEC, isolated from pigs, produced alpha-Hemolysin. The correlation of SLT-containing strains and the production of enterohemolysin was confirmed for ruminants, only. Plasmidprofilings of VTEC from pigs showed mainly a 60 MDa or a 68 MDa plasmid or both, too. The occurrence of heat labile (LT) and in some cases of heat stable (ST) toxin was also checked, to differentiate the VTEC-strains from the enterotoxigenic E. coli strains (ETEC). These investigations showed, that VTEC produce SLT almost without exception. Correlations and conclusions on the pathogenicity for humans are discussed.

Animals↗

Neurite outgrowth of neurons of rat dorsal root ganglia induced by new neurotrophic substances with guanidine group.

In order to search for compounds mimicking the neurotrophic activities, a series of substances possessing the guanidine group of isaxonine (2-isopropylamino-pyrimidine), were synthesized and tested for their ability to induce neurite outgrowth in cultures of explants of rat dorsal root ganglia. It is reported that several of these compounds, at concentrations ranging from 10(-5) to 10(-7) M, showed important effects on neurite outgrowth in vitro, similar to that obtained with the nerve growth factor NGF. These effects were found to be additive to that of NGF.

Animals↗

Lesion-induced re-expression of neonatal recognition molecules in adult rat cerebellum.

It has been previously shown that sectioning of parallel fibers in the cerebellar molecular layer of adult rats gave rise to rapid reinnervation of the target cells, i.e., Purkinje cells. This paper reports that such a reinnervation is accompanied by reexpression (partial and total) of two developmentally regulated complementary molecules. These are an endogenous mannose-binding lectin, called R1, which reappears at the surface of the dendrites of Purkinje cells, and an endogenous glycoprotein ligand of R1, the 31 kDa glycoprotein, which seems to be neosynthetized and transported to the surface of parallel fibers. In this system, embryonic N-CAM is not reexpressed in neurons but reappears in reactive astrocytes in the vicinity of the lesion. The reexpression of recognition molecules (lectin and glycoprotein ligand) involved in normal synaptogenesis, may constitute the molecular basis for repair of nervous circuits in the adult as well.

Animals↗

Nutritional support in the hypermetabolic patient.

A patient who has experienced a major injury needs to undergo a careful assessment for hypermetabolism and malnutrition. Metabolic supportive therapy focuses on the support of the structural and functional integrity of organs and organ systems. The principles are derived from an understanding of the metabolic and physiologic responses to injury. When supportive therapy is applied in this manner, the chance of recovery can be significantly affected.

Critical Illness↗

Glycoproteins and lectins in cell adhesion and cell recognition processes.

The discovery of endogenous lectins having specific and high affinity for the carbohydrate portions of glycoproteins has opened up new directions in the field of cell adhesion and cell recognition. Two endogenous lectins, termed as CSL and R1, initially isolated from the rat cerebellum and having a wide distribution in mammalian tissues, have been shown to participate in essential mechanisms of cell adhesion. The membrane-bound lectin R1 seems to be involved in transient recognition between neuronal cells, followed by elimination of the glycoprotein ligands at the surface of the recognized cell. In contrast, CSL is a molecule involved in adhesion between various normal or transformed cells since it participates in the formation of tight junctions. The glycoprotein ligands recognized with higher affinity by these two lectins seem to possess a special structure which defines a sub-class of oncofetal HNK-1 glycans. The over-expression of the glycoprotein ligands of these lectins in most transformed cells provides new tools for understanding the underlying mechanism of malignant transformation as well as the generation of signals through cell adhesion.

Animals↗

Cerebrospinal fluid anti-cerebellar soluble lectin antibodies in human immunodeficiency virus type 1 infection.

Cerebrospinal fluid samples from 14 human immunodeficiency type 1 (HIV-1) seropositive patients in various stages of HIV infection were tested for the presence of autoantibodies to an endogenous manose-binding protein, the cerebellar soluble lectin (CSL), which has recently been found to be detected in a high proportion of patients with multiple sclerosis. An immunoblotting test was used with rat CSL as antigen. Seven patients were positive for anti-CSL and seven were negative. The seven anti-CSL-positive patients had signs of intrathecal immunoglobulin G production measured as an elevated IgG index, while the seven anti-CSL-negative patients had a normal IgG index. There was no apparent relation between infectious stage and the presence of anti-CSL. Immunological reactions such as anti-CSL autoantibodies may be a similar pathogenic mechanism in HIV and multiple sclerosis brain disease.

Acquired Immunodeficiency Syndrome↗

Endogenous lectin cerebellar soluble lectin involved in myelination is absent from nonmyelinating Schwann cells.

In the sciatic nerve, two major classes of Schwann cells are present which differ in their capability to produce myelin. Myelinating Schwann cells surround most of the axons with the formation of a typical myelin sheath. Nonmyelinating Schwann cells serve to insulate individual axons without formation of myelin. These dissimilarities between the two types of Schwann cells provided an interesting model for studying mechanisms underlying myelination and the formation of contacts between axons and myelinating cells. It is demonstrated here that the endogenous lectin cerebellar soluble lectin (CSL), implicated in myelin stabilization and in formation of contact between axon and myelinating cells in the CNS and in the sciatic nerve, is undetectable in non-myelinating Schwann cells. In contrast, most axons surrounded by these cells contained the major axonal glycoprotein ligand of CSL, a 31-kDa glycoprotein which is present in large amounts. The possible relationship between the presence of CSL in Schwann cells and their capacity to interact with axons and to produce myelin are discussed.

Animals↗

Growth hormone and nutritional support: adverse metabolic effects.

The use of growth hormone in clinical nutritional support has received considerable attention over the past decade. The most encouraging results have been improved nitrogen retention and protein synthesis in the presence of hypocaloric nutritional support. Adverse effects, however, can limit the clinical usefulness of this technology. In the following case study, an obese 71-year-old man with a history of chronic obstructive pulmonary disease remained ventilator dependent 2 months following anterior cervical fusion and had severe depletion of visceral proteins despite nitrogen equilibrium. He was treated with 10 mg of recombinant human growth hormone (Genentech) subcutaneously every other day while also receiving nutritional support. We hypothesized that growth hormone administration could promote both protein synthesis and the development of muscle mass, particularly in the respiratory muscles, without increasing nutrient intake and, therefore, without increasing CO2 production. The patient, however, developed two potentially life-threatening adverse effects: hyperglycemia and fluid retention. The severity of these adverse effects led to discontinuation of this mode of therapy.

Aged↗